These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23187959)

  • 1. Thrombocytosis is a marker of poor outcome in community-acquired pneumonia.
    Prina E; Ferrer M; Ranzani OT; Polverino E; Cillóniz C; Moreno E; Mensa J; Montull B; Menéndez R; Cosentini R; Torres A
    Chest; 2013 Mar; 143(3):767-775. PubMed ID: 23187959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia.
    Mirsaeidi M; Peyrani P; Aliberti S; Filardo G; Bordon J; Blasi F; Ramirez JA
    Chest; 2010 Feb; 137(2):416-20. PubMed ID: 19837825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can thrombocytosis or thrombocytopenia predict complicated clinical course and 30-days mortality in patients with pneumonia?
    Mısıroğlu RS; Aksay E; Şancı E; Tertemiz KC
    Turk J Med Sci; 2021 Dec; 51(6):2903-2907. PubMed ID: 34118803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
    Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
    Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.
    Cilli A; Erdem H; Karakurt Z; Turkan H; Yazicioglu-Mocin O; Adiguzel N; Gungor G; Bilge U; Tasci C; Yilmaz G; Oncul O; Dogan-Celik A; Erdemli O; Oztoprak N; Samur AA; Tomak Y; Inan A; Karaboga B; Tok D; Temur S; Oksuz H; Senturk O; Buyukkocak U; Yilmaz-Karadag F; Ozcengiz D; Karakas A; Savasci U; Ozgen-Alpaydın A; Kilic E; Elaldi N; Bilgic H
    J Crit Care; 2013 Dec; 28(6):975-9. PubMed ID: 24075301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.
    Lee JH; Chung HJ; Kim K; Jo YH; Rhee JE; Kim YJ; Kang KW
    Am J Emerg Med; 2013 Jan; 31(1):72-9. PubMed ID: 22867824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia.
    Gorelik O; Izhakian S; Barchel D; Almoznino-Sarafian D; Tzur I; Swarka M; Beberashvili I; Feldman L; Cohen N; Shteinshnaider M
    Platelets; 2017 Jun; 28(4):380-386. PubMed ID: 27682027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small pericardial effusion is a marker of complicated hospitalization in patients with community-acquired pneumonia.
    Biteker FS; Biteker M; Başaran Ö; Doğan V; Özlek B; Yıldırım B; Özlek E; Çelik O
    J Crit Care; 2018 Apr; 44():294-299. PubMed ID: 29247912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
    Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
    Liu S; He LR; Wang W; Wang GH; He ZY
    Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of mean platelet volume and the CURB-65 score better predicts 28-day mortality in patients with community-acquired pneumonia.
    Golcuk Y; Golcuk B; Bilge A; Irik M; Dikmen O
    Am J Emerg Med; 2015 May; 33(5):648-52. PubMed ID: 25687620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
    J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study.
    Kohno S; Seki M; Takehara K; Yamada Y; Kubo K; Ishizaka A; Soma K
    Respiration; 2013; 85(1):27-35. PubMed ID: 22343936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
    Dremsizov T; Clermont G; Kellum JA; Kalassian KG; Fine MJ; Angus DC
    Chest; 2006 Apr; 129(4):968-78. PubMed ID: 16608946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive thrombocytosis in acute infectious diseases: Prevalence, characteristics and timing.
    Schattner A; Kadi J; Dubin I
    Eur J Intern Med; 2019 May; 63():42-45. PubMed ID: 30795883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
    Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
    PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.